Paul S. Carter
GlaxoSmithKline (United Kingdom)(GB)
Publications by Year
Research Areas
RNA and protein synthesis mechanisms, Wnt/β-catenin signaling in development and cancer, Mast cells and histamine, Melanoma and MAPK Pathways, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Catalytic in vivo protein knockdown by small-molecule PROTACs(2015)1,271 cited
- → Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription(2000)888 cited
- → The Structure of Phosphorylated GSK-3β Complexed with a Peptide, FRATtide, that Inhibits β-Catenin Phosphorylation(2001)198 cited
- → The antimicrobial natural product chuangxinmycin and Some synthetic analogues are potent and selective inhibitors of bacterial tryptophanyl tRNA synthetase(2002)138 cited
- → Necrotising fasciitis: a new management algorithm based on clinical classification(2004)66 cited
- → Expression, Purification, and Functional Analysis of the Human Serine Protease HtrA2(2000)59 cited
- → Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor(2011)54 cited
- → The Structure of MSK1 Reveals a Novel Autoinhibitory Conformation for a Dual Kinase Protein(2004)47 cited
- → Rapid Lentiviral Vector Producer Cell Line Generation Using a Single DNA Construct(2020)43 cited
- → The Discovery of in Vivo Active Mitochondrial Branched-Chain Aminotransferase (BCATm) Inhibitors by Hybridizing Fragment and HTS Hits(2015)42 cited